Who
Ping Wang Rawson
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Dyadic International; Director, Leverage Shares MANGOS ETF.
In numbers
- Trades disclosed
- 23
- Buys
- 3
- Sells
- 0
- Bought
- $100K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 28 Jun 2019
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | —29,158 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —47,250 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —47,250 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | —29,158 at $0.00 | filing |
| 2 Jan 2025filed 7 Jan 2025 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —64,500 at $0.00 | filing |
| 2 Jan 2025filed 7 Jan 2025 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | —20,776 at $0.00 | filing |
| 5 Aug 2024filed 7 Aug 2024 | MGOL Leverage Shares MANGOS ETF | SEC FORM 4 Code A | —1,100 at $0.00 | filing |
| 4 Jun 2024filed 5 Jun 2024 | MGOL Leverage Shares MANGOS ETF | SEC FORM 4 Code A | —89,186 at $0.00 | filing |
| 23 Apr 2024filed 25 Apr 2024 | MGOL Leverage Shares MANGOS ETFoption or derivative | SEC FORM 4 Code J | —20,000 at $0.00 | filing |
| 23 Apr 2024filed 25 Apr 2024 | MGOL Leverage Shares MANGOS ETF | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 13 Mar 2024filed 15 Apr 2024 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | —35,366 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | $54K39,351 at $1.38 | filing |
| 3 Jan 2022filed 5 Jan 2022 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 3 Jun 2021filed 4 Jun 2021 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Bought | $4,8601,350 at $3.60 | filing |
| 3 Jun 2021filed 4 Jun 2021 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Bought | $12K3,320 at $3.60 | filing |
| 2 Jun 2021filed 4 Jun 2021 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Bought | $24K6,156 at $3.83 | filing |
| 2 Jun 2021filed 4 Jun 2021 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Bought | $677174 at $3.89 | filing |
| 2 Jun 2021filed 3 Jun 2021 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Bought | $59K16,000 at $3.70 | filing |
News
Contrasting Dyadic International (NASDAQ:DYAI) and Pharming Group (NASDAQ:PHAR)DYAI · themarketsdaily.com · 6 Oct 2026
0 headlines in the last 90 days name Ping Wang Rawson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.